Impaired expression of protein phosphatase 2A subunits enhances metastatic potential of human prostate cancer cells through activation of AKT pathway.
about
Cellular prostatic acid phosphatase, a PTEN-functional homologue in prostate epithelia, functions as a prostate-specific tumor suppressorAmyloid precursor-like protein 2 (APLP2) affects the actin cytoskeleton and increases pancreatic cancer growth and metastasis.CIP2A is a candidate therapeutic target in clinically challenging prostate cancer cell populations.Inhibition of Pten deficient Castration Resistant Prostate Cancer by Targeting of the SET - PP2A Signaling axis.Protein phosphatase 1 suppresses androgen receptor ubiquitylation and degradation.PR55α Subunit of Protein Phosphatase 2A Supports the Tumorigenic and Metastatic Potential of Pancreatic Cancer Cells by Sustaining Hyperactive Oncogenic Signaling.Conditional Knockout in Mice Reveals the Critical Roles of Ppp2ca in Epidermis DevelopmentProtein phosphatase-2A is down-regulated in patients within clear cell renal cell carcinoma.hPaf1/PD2 interacts with OCT3/4 to promote self-renewal of ovarian cancer stem cells.OP449 inhibits breast cancer growth without adverse metabolic effects.Restoration of PPP2CA expression reverses epithelial-to-mesenchymal transition and suppresses prostate tumour growth and metastasis in an orthotopic mouse model.Activation of the Tumor Suppressor PP2A Emerges as a Potential Therapeutic Strategy for Treating Prostate Cancer.Aloperine Protects Mice against DSS-Induced Colitis by PP2A-Mediated PI3K/Akt/mTOR Signaling Suppression.Small molecule activators of protein phosphatase 2A for the treatment of castration-resistant prostate cancer.PP2A inhibition as a novel therapeutic target in castration-resistant prostate cancer.Knockdown of Yin Yang 1 enhances anticancer effects of cisplatin through protein phosphatase 2A-mediated T308 dephosphorylation of AKT.
P2860
Q26863333-30CF906F-D069-49F1-B885-2D1CE322BD48Q30300982-F371DE23-2505-4AEC-AF8E-B1FA1AF1159EQ36260616-22304C62-894E-4F39-98DF-92FD5BBE67FFQ36275673-4EFC5D90-59E7-47C3-B211-A42B742D9B8EQ36738961-D1B231F6-7A7A-44CE-8CAC-5F588D42D1CDQ36917818-BF89E2EE-D745-4BCC-8C27-FD2F373F51C7Q36939325-7C2E0CCD-17CE-4D6D-9A58-570A26F84238Q37676786-0AD5DEB8-2D91-45FD-BA9B-D1254D2F3B6FQ37716449-15444A19-21F3-4F4A-B081-5104E4FB7248Q38613399-62F1F35D-3E93-4C71-8DF3-4F6C2AD12AD9Q38838867-A0045FE9-6A4F-4C8E-A75A-FFE72144C850Q38869675-4421D862-18E0-4509-A501-89781A651996Q47152525-55AADEE7-EE10-4701-8C21-FDAD72FEC1CFQ50091777-BA460D1E-3588-4F79-A894-EC4FBA17BC91Q53398122-265A0D86-E719-4838-9A2C-56BC446FC86CQ55447366-16868D6D-6597-4A73-BD6C-715171FB23E1
P2860
Impaired expression of protein phosphatase 2A subunits enhances metastatic potential of human prostate cancer cells through activation of AKT pathway.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Impaired expression of protein ...... ugh activation of AKT pathway.
@en
type
label
Impaired expression of protein ...... ugh activation of AKT pathway.
@en
prefLabel
Impaired expression of protein ...... ugh activation of AKT pathway.
@en
P2093
P2860
P356
P1476
Impaired expression of protein ...... ough activation of AKT pathway
@en
P2093
M Fong Lin
M P Ponnusamy
S L Johansson
S Rachagani
P2860
P2888
P304
P356
10.1038/BJC.2013.160
P407
P577
2013-04-18T00:00:00Z